Inquiry Into Foreign Bribes at Biomet Hangs Over $13 Billion Merger (NYTimes)
From the skyscrapers of Wall Street to the factories of northern Indiana, cheers rang out for one of the biggest mergers of the year. For $13.35 billion, Goldman Sachs and a group of giant private equity firms agreed in April to sell one Indiana medical device maker to another.
But possible acts of bribery abroad may have complicated that deal — and raised larger questions about the way prosecutors mete out justice for big corporations, according to confidential documents reviewed by The New York Times and interviews...
